A Study to Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure
Clinical trial NCT00510913 · COMPLETED
Trial details
- NCT number
- NCT00510913
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 1999-02-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.